Similar to other highly homologous members of the TNF ligand family, TRAIL was originally regarded as a cytokine that selectively induces apoptosis in a variety of cancer cell lineages or transformed target cells,3 and leaving normal cells unaffected.4 Here, TNFSF10 is linked to cancer.